Efficacy and safety of acupuncture for cancer-related fatigue in patients with breast cancer: a randomized, single-blinded, controlled trial

Beijing Administration of Traditional Chinese Medicine (China)0 个研究点目标入组 40 人开始时间: 2014年4月24日最近更新: 2020年8月3日

适应症

试验速览

暂无简介。

•1. Women patients with a definite pathologic diagnosis of breast cancer who had complete chemotherapy and/or radiotherapy at least 1 month before and mastectomy within 5 years
•2. Stage I-III breast cancer with no evidence of recurrence and metastasis
•3. Eastern Cooperative Oncology Group (ECOG) performance status 0-2
•4. Anticipated survival time is more than 6 months
•5. Aged 18-65
•6. Patients who are suffering from at least moderate fatigue by Revised Piper Fatigue Scale-Chinese Version (RPFS-CV)
•7. All patients provided written informed consent before enrollment

•1. Complicated with other primary tumors and serious heart, liver, kidney and hematopoietic system diseases
•2. Pregnant women or women who are breastfeeding
•3. Patients who had needle phobia
•4. Patients who had low platelet count or suffered from a bleeding disorder (e.g., haemophilia)
•5. Patients who had lymphoedema at the area of the acupuncture points
•6. Patients who were on active treatment for anaemia (i.e., EPO or blood transfusions)
•7. Patients who were receiving steroids to combat fatigue
•8. Patients who had been diagnosed with depression, anxiety disorders, mental illness and cognitive disorders

发起方

Beijing Administration of Traditional Chinese Medicine (China)